Health and Healthcare

Merck : MRK

All Merck Articles

1067 Articles

Chris Lange | Jun 12, 2019 at 8:30 AM EDT

Big Pharma Sees a Rising Tide in Short Interest

The May 31 short interest data have been compared with the previous figures, and short interest in most of these…

Chris Lange | May 28, 2019 at 8:50 AM EDT

Big Pharma Short Sellers Hike Their Bets

The May 15 short interest data have been compared with the previous figures, and short interest in most of these…

Jon C. Ogg | May 13, 2019 at 8:55 AM EDT

Top Analyst Upgrades and Downgrades: Alarm.com, Exxon, Goldman Sachs BDC, Merck, Pinterest, Shopify, Wendy’s, Zoom Video and More

The top analyst upgrades, downgrades and initiations seen on Monday included Alarm.com, Exxon Mobil, Goldman Sachs BDC, Merck, Pinterest, Shopify,…

Chris Lange | May 10, 2019 at 10:15 AM EDT

Big Pharma Scares Off Short Sellers

The April 30 short interest data have been compared with the previous figures, and short interest in most of these…

Jon C. Ogg | May 2, 2019 at 9:00 AM EDT

Top Analyst Upgrades and Downgrades: American Water, Arconic, Cree, Dell, Humana, Merck, Qualcomm, Square, Tesla, Zynga and More

The top analyst upgrades, downgrades and initiations seen on Thursday included American Water Works, Arconic, Cree, Dell Technologies, Humana, Merck,…

Chris Lange | Apr 28, 2019 at 10:20 AM EDT

Apple, McDonald’s, Pfizer and More Dow Stocks Reporting This Week

24/7 Wall St. has put together a preview of Apple, Pfizer and other Dow companies scheduled to report their quarterly…

Chris Lange | Apr 26, 2019 at 8:45 AM EDT

Big Pharma Scares Off Short Sellers

The April 15 short interest data have been compared with the previous figures, and short interest in most of these…

Jon C. Ogg | Apr 24, 2019 at 7:10 AM EDT

15 Great Dividend Stocks Retirees Should Own in 2019

Here is a slate of 15 companies that most retirees likely would want to own in their portfolio now, including…

Chris Lange | Apr 10, 2019 at 9:40 AM EDT

Unbelievable Swings in Big Pharma Short Interest

The March 29 short interest data have been compared with the previous figures, and short interest in most of these…

Jon C. Ogg | Mar 27, 2019 at 3:55 PM EDT

Why Pfizer May Soon Make Up Lost Ground in Underperforming Against Merck

According to Credit Suisse, Pfizer investors might be getting to make up some of that relative underperformance of late.

Chris Lange | Mar 27, 2019 at 8:50 AM EDT

Major Pharma Sees a Few Wild Swings in Short Interest

The March 15 short interest data have been compared with the previous figures, and short interest in most of these…

Jon C. Ogg | Mar 25, 2019 at 12:10 PM EDT

The 10 Companies Buying Back the Most Stock

Stock buybacks have come under more scrutiny by the public and politicians in recent years, but companies still aggressively are…

Jon C. Ogg | Mar 22, 2019 at 1:45 PM EDT

As Recession Fears Grow, 15 Stocks to Survive a Stock Market Correction

During times of uncertainty and fear, many investors have to look for a place to hide when they know that…

Chris Lange | Mar 12, 2019 at 8:35 AM EDT

Big Pharma Short Interest Backs Off, With One Huge Exception

The February 28 short interest data have been compared with the previous figures, and short interest in most of these…

Lee Jackson | Mar 1, 2019 at 7:30 AM EST

5 Safe Merrill Lynch US 1 List Stocks to Buy That Pay Big Dividends

These five outstanding ideas from Merrill Lynch are decidedly more conservative. Given their strong and consistent dividends, they offer investors…

1 … 15 16 17 18 19 … 72

Merck : MRK

All Merck Articles

Big Pharma Sees a Rising Tide in Short Interest

Big Pharma Short Sellers Hike Their Bets

Top Analyst Upgrades and Downgrades: Alarm.com, Exxon, Goldman Sachs BDC, Merck, Pinterest, Shopify, Wendy’s, Zoom Video and More

Big Pharma Scares Off Short Sellers

Top Analyst Upgrades and Downgrades: American Water, Arconic, Cree, Dell, Humana, Merck, Qualcomm, Square, Tesla, Zynga and More

Apple, McDonald’s, Pfizer and More Dow Stocks Reporting This Week

Big Pharma Scares Off Short Sellers

15 Great Dividend Stocks Retirees Should Own in 2019

Unbelievable Swings in Big Pharma Short Interest

Why Pfizer May Soon Make Up Lost Ground in Underperforming Against Merck

Major Pharma Sees a Few Wild Swings in Short Interest

The 10 Companies Buying Back the Most Stock

As Recession Fears Grow, 15 Stocks to Survive a Stock Market Correction

Big Pharma Short Interest Backs Off, With One Huge Exception

5 Safe Merrill Lynch US 1 List Stocks to Buy That Pay Big Dividends

This High-Yield Emerging Funds ETF Offers International Diversification

A 71-Year-Old’s $850,000 Home Is Her Biggest Retirement Asset. Downsizing Could Add $2,250 a Month

Why The Money Guy’s 25% Savings Rule Actually Starts at 15%

A 71-Year-Old's $850,000 Home Is Her Biggest Retirement Asset. Downsizing Could Add $2,250 a Month

Why The Money Guy's 25% Savings Rule Actually Starts at 15%

SMH Has Crushed the S&P 500 by 2,041% Over a Decade, But Recent 42% Rally Signals Dangerous Valuations

This High-Yield Emerging Funds ETF Offers International Diversification

Merck : MRK

All Merck Articles

Big Pharma Sees a Rising Tide in Short Interest

Big Pharma Short Sellers Hike Their Bets

Top Analyst Upgrades and Downgrades: Alarm.com, Exxon, Goldman Sachs BDC, Merck, Pinterest, Shopify, Wendy’s, Zoom Video and More

Big Pharma Scares Off Short Sellers

Top Analyst Upgrades and Downgrades: American Water, Arconic, Cree, Dell, Humana, Merck, Qualcomm, Square, Tesla, Zynga and More

Apple, McDonald’s, Pfizer and More Dow Stocks Reporting This Week

Big Pharma Scares Off Short Sellers

15 Great Dividend Stocks Retirees Should Own in 2019

Unbelievable Swings in Big Pharma Short Interest

Why Pfizer May Soon Make Up Lost Ground in Underperforming Against Merck

Major Pharma Sees a Few Wild Swings in Short Interest

The 10 Companies Buying Back the Most Stock

As Recession Fears Grow, 15 Stocks to Survive a Stock Market Correction

Big Pharma Short Interest Backs Off, With One Huge Exception

5 Safe Merrill Lynch US 1 List Stocks to Buy That Pay Big Dividends

This High-Yield Emerging Funds ETF Offers International Diversification

A 71-Year-Old’s $850,000 Home Is Her Biggest Retirement Asset. Downsizing Could Add $2,250 a Month

Why The Money Guy’s 25% Savings Rule Actually Starts at 15%

Featured Reads

A 71-Year-Old's $850,000 Home Is Her Biggest Retirement Asset. Downsizing Could Add $2,250 a Month

Why The Money Guy's 25% Savings Rule Actually Starts at 15%